Radon Oncology Profile
Key Indicators
- Authorised Capital ₹ 8.00 Cr
as on 16-07-2024
- Paid Up Capital ₹ 7.19 Cr
as on 16-07-2024
- Company Age 12 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 20.10 Cr
as on 16-07-2024
- Satisfied Charges ₹ 5.80 M
as on 16-07-2024
- Revenue 4.35%
(FY 2023)
- Profit -13.01%
(FY 2023)
- Ebitda -10.91%
(FY 2023)
- Net Worth 21.95%
(FY 2023)
- Total Assets -4.43%
(FY 2023)
About Radon Oncology
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 8.00 Cr and a paid-up capital of Rs 7.19 Cr.
The company currently has active open charges totaling ₹20.10 Cr. The company has closed loans amounting to ₹5.80 M, as per Ministry of Corporate Affairs (MCA) records.
Shashikant Kulgod and Sanjeev Kulgod serve as directors at the Company.
- CIN/LLPIN
U85100KA2012PTC065541
- Company No.
065541
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Aug 2012
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Hubli, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Radon Oncology?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shashikant Kulgod  | Director | 24-Aug-2012 | Current |
| Sanjeev Kulgod | Director | 24-Aug-2012 | Current |
Financial Performance and Corporate Structure Insights of Radon Oncology.
Radon Oncology Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.35% increase. The company also saw a substantial fall in profitability, with a 13.01% decrease in profit. The company's net worth Soared by an impressive increase of 21.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Radon Oncology?
In 2023, Radon Oncology had a promoter holding of 58.22% and a public holding of 41.78%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Brahmadanda Healthcare Solutions Private LimitedActive 15 years 5 monthsShashikant Kulgod is a mutual person
Brahmadanda Imaging And Diagnostics Private LimitedActive 14 years 8 monthsShashikant Kulgod is a mutual person
- Kayaka Sanjeevani Health Systems Private LimitedActive 12 years 7 months
Shashikant Kulgod is a mutual person
- Rajalakshmi Children FoundationActive 11 years 10 months
Shashikant Kulgod and Sanjeev Kulgod are mutual person
- Vigilomics Biosciences Private LimitedActive 7 months 27 days
Shashikant Kulgod and Sanjeev Kulgod are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 20 Nov 2017 | ₹10.00 Cr | Open |
State Bank Of India Creation Date: 06 May 2016 | ₹10.10 Cr | Open |
Karnataka Bank Ltd. Creation Date: 16 Sep 2014 | ₹5.80 M | Satisfied |
How Many Employees Work at Radon Oncology?
Radon Oncology has a workforce of 71 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Radon Oncology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Radon Oncology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
